---
document_datetime: 2023-09-21 16:59:44
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/levetiracetam-actavis-group-epar-all-authorised-presentations_en.pdf
document_name: levetiracetam-actavis-group-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9041337
conversion_datetime: 2025-12-20 13:56:47.307693
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Name                        | Strength   | Pharmaceutical Form   | Route of Administration   | Packaging      | Content   | Package size                             |
|-----------------|-----------------------------|------------|-----------------------|---------------------------|----------------|-----------|------------------------------------------|
| EU/1/11/738/001 | Levetiracetam Actavis Group | 100 mg/ml  | Oral solution         | Oral use                  | bottle (glass) | 300 ml    | 1 bottle + 1 oral syringe 10 ml          |
| EU/1/11/738/002 | Levetiracetam Actavis Group | 100 mg/ml  | Oral solution         | Oral use                  | bottle (glass) | 300 ml    | 1 bottle + 1 oral syringe 1 ml + adaptor |
| EU/1/11/738/003 | Levetiracetam Actavis Group | 100 mg/ml  | Oral solution         | Oral use                  | bottle (glass) | 300 ml    | 1 bottle + 1 oral syringe 3 ml + adaptor |